BioMaxima S.A. (BMX.WA)
PLN 11.7
(-2.5%)
PLN 11.7
(-2.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 201 Thousand PLN | -101.83% |
| 2022 | 34.85 Million PLN | 155.28% |
| 2021 | 13.65 Million PLN | 44.36% |
| 2020 | 9.45 Million PLN | 1284.02% |
| 2019 | 683.34 Thousand PLN | 376.13% |
| 2018 | -247.47 Thousand PLN | -123.3% |
| 2017 | 1.06 Million PLN | -27.95% |
| 2016 | 1.47 Million PLN | -16.21% |
| 2015 | 1.75 Million PLN | 167.4% |
| 2014 | 657.79 Thousand PLN | -61.64% |
| 2013 | 1.71 Million PLN | -11.12% |
| 2012 | 1.92 Million PLN | 36.96% |
| 2011 | 1.4 Million PLN | 73.9% |
| 2010 | 810 Thousand PLN | 4.82% |
| 2009 | 772.75 Thousand PLN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 50 Thousand PLN | 132.68% |
| 2024 Q2 | 18 Thousand PLN | -64.0% |
| 2023 Q3 | -574 Thousand PLN | -165.9% |
| 2023 FY | -638 Thousand PLN | -101.83% |
| 2023 Q1 | 461 Thousand PLN | 2.22% |
| 2023 Q2 | 871 Thousand PLN | 88.94% |
| 2023 Q4 | -153 Thousand PLN | 73.34% |
| 2022 FY | 34.85 Million PLN | 155.28% |
| 2022 Q1 | 30.22 Million PLN | 755.93% |
| 2022 Q2 | 3.56 Million PLN | -88.22% |
| 2022 Q3 | 898 Thousand PLN | -74.78% |
| 2022 Q4 | 451 Thousand PLN | -49.78% |
| 2021 Q4 | 3.53 Million PLN | 141.02% |
| 2021 Q1 | 7.94 Million PLN | 96.62% |
| 2021 Q2 | 824 Thousand PLN | -89.63% |
| 2021 FY | 13.65 Million PLN | 44.36% |
| 2021 Q3 | 1.46 Million PLN | 77.79% |
| 2020 Q4 | 4.04 Million PLN | 227.14% |
| 2020 Q2 | 3.71 Million PLN | 697.26% |
| 2020 Q1 | 466.11 Thousand PLN | -38.97% |
| 2020 FY | 9.45 Million PLN | 1284.02% |
| 2020 Q3 | 1.23 Million PLN | -66.77% |
| 2019 FY | 683.34 Thousand PLN | 376.13% |
| 2019 Q1 | -20.21 Thousand PLN | 96.57% |
| 2019 Q2 | -6922.00 PLN | 65.76% |
| 2019 Q3 | -107.49 Thousand PLN | -1452.89% |
| 2019 Q4 | 763.69 Thousand PLN | 810.47% |
| 2018 Q2 | 668.22 Thousand PLN | 160.77% |
| 2018 FY | -247.47 Thousand PLN | -123.3% |
| 2018 Q1 | 256.24 Thousand PLN | 53.26% |
| 2018 Q3 | -582.97 Thousand PLN | -187.24% |
| 2018 Q4 | -588.96 Thousand PLN | -1.03% |
| 2017 FY | 1.06 Million PLN | -27.95% |
| 2017 Q2 | 95.82 Thousand PLN | -75.53% |
| 2017 Q1 | 391.59 Thousand PLN | -25.98% |
| 2017 Q4 | 167.19 Thousand PLN | -62.32% |
| 2017 Q3 | 443.74 Thousand PLN | 363.08% |
| 2016 Q1 | 529.62 Thousand PLN | 7.73% |
| 2016 Q4 | 529.01 Thousand PLN | 189.09% |
| 2016 Q3 | 182.99 Thousand PLN | -21.2% |
| 2016 Q2 | 232.21 Thousand PLN | -56.16% |
| 2016 FY | 1.47 Million PLN | -16.21% |
| 2015 Q2 | 386.34 Thousand PLN | -22.97% |
| 2015 FY | 1.75 Million PLN | 167.4% |
| 2015 Q1 | 501.56 Thousand PLN | 118.72% |
| 2015 Q4 | 491.62 Thousand PLN | 29.57% |
| 2015 Q3 | 379.41 Thousand PLN | -1.79% |
| 2014 Q3 | -170.42 Thousand PLN | -190.76% |
| 2014 Q2 | 187.77 Thousand PLN | -54.33% |
| 2014 Q1 | 411.13 Thousand PLN | 37.05% |
| 2014 Q4 | 229.31 Thousand PLN | 234.55% |
| 2014 FY | 657.79 Thousand PLN | -61.64% |
| 2013 Q3 | 537.69 Thousand PLN | 33.46% |
| 2013 Q4 | 299.97 Thousand PLN | -44.21% |
| 2013 FY | 1.71 Million PLN | -11.12% |
| 2013 Q1 | 427.75 Thousand PLN | -69.34% |
| 2013 Q2 | 402.87 Thousand PLN | -5.82% |
| 2012 Q1 | 270.81 Thousand PLN | 0.0% |
| 2012 FY | 1.92 Million PLN | 36.96% |
| 2012 Q2 | 78 Thousand PLN | -71.2% |
| 2012 Q4 | 1.39 Million PLN | 995.11% |
| 2012 Q3 | 127.38 Thousand PLN | 63.3% |
| 2011 FY | 1.4 Million PLN | 73.9% |
| 2010 FY | 810 Thousand PLN | 4.82% |
| 2009 FY | 772.75 Thousand PLN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Scope Fluidics S.A. | -28.68 Million PLN | 100.701% |
| Selvita S.A. | 69.31 Million PLN | 99.71% |
| Voxel S.A. | 112.71 Million PLN | 99.822% |